SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance
Cardiovascular Research · 06.05.2025 · 121 (4) · 643-657
DOI: 10.1093/cvr/cvae257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 31.12.2024. Verfasst von Ali Mroueh und 16 weiteren Autor:innen. Beteiligte Einrichtung: Translational Cardiovascular Medicine UR 3074, FMTS, 1 rue Eugène Boeckel, Strasbourg 67084, France. Hauptthemen laut MEDLINE: Inflammation, Reactive Oxygen Species, Sodium-Glucose Transporter 2, Endothelial Cells. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany, Groupe pour l'Enseignement, la prévention et la Recherche Cardiologique en Alsace, Groupe pour l’Enseignement, la prévention et la Recherche Cardiologique en Alsace.
Abstract (Originalsprache)
Aims
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) show a cardioprotective effect in heart failure and myocardial infarction, pathologies often associated with low-grade inflammation. This cross-sectional study aims to investigate whether low-grade inflammation regulates SGLT2 expression and function in human vasculature, heart, and endothelial cells (ECs). Methods and results Human internal thoracic artery (ITA), left ventricle (LV) specimens, and cultured porcine coronary artery ECs were used. Expression of target molecules was assessed using RT-qPCR, western blot analysis, and immunofluorescence staining, and the generation of reactive oxygen species (ROS) and nitric oxide (NO) using fluorescent probes. The function of SGLT2 was investigated using empagliflozin and SGLT1 or 2 siRNA. SGLT2 mRNA and protein levels in ITA and LV specimens were correlated with the level of low-grade inflammation, markers of the angiotensin system, and EC activation. SGLT2 staining was observed in the ITA endothelium and smooth muscle, the coronary microcirculation, and cardiomyocytes. Elevated ROS formation in high SGLT2-expressing specimens was reduced by inhibition of the angiotensin system, SGLT2, and TNF-α. Exposure of ECs to IL-1ß, IL-6, and TNF-α led to an increase in SGLT1 and SGLT2 mRNA and protein expression, up-regulation of components of the angiotensin system, enhanced ROS and decreased NO formation, and activation of NF-κB. The stimulatory effect of TNF-α was prevented by N-acetylcysteine and inhibition of the angiotensin system, SGLT2 but not SGLT1, and NF-κB.
Conclusion
Low-grade inflammation is closely associated with SGLT2 expression in human vasculature and heart, and this response contributes to a feedforward mechanism with the AT1R/NADPH oxidase pathway to cause eNOS-NO/ROS imbalance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Cardiovascular Medicine UR 3074, FMTS, 1 rue Eugène Boeckel, Strasbourg 67084, France.
- Faculty of Pharmacy, Strasbourg University, Strasbourg 67000, France.
- Division of Cardiovascular Medicine, Nouvel Hoôpital Civil, Strasbourg University Hospital, Strasbourg, France.
- Department of Biostatistics, Strasbourg University Hospital, Strasbourg, France.
- Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
- Division of Cardiac Surgery and Heart Transplant, Nouvel Hoôpital Civil, Strasbourg University Hospital, Strasbourg 67091, France.
ORCID-Profile: Ali Mroueh, Walaa Fakih, Kensuke Matsushita, Patrick Ohlmann, Benjamin Marchandot, Olivier Morel, Valérie B Schini-Kerth
Förderung
- Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
- Groupe pour l'Enseignement, la prévention et la Recherche Cardiologique en Alsace
- Groupe pour l’Enseignement, la prévention et la Recherche Cardiologique en Alsace
Zitieren
APA
Mroueh, A., Algara-Suarez, P., Fakih, W., Gong, D. S., Matsushita, K., Park, S. H., Amissi, S., Auger, C., Kauffenstein, G., Meyer, N., Ohlmann, P., Jesel, L., Pieper, M. P., Marchandot, B., Morel, O., Mazzucotelli, J. P., & Schini-Kerth, V. B. (2025). SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance. Cardiovascular Research, 121(4), 643-657. https://doi.org/10.1093/cvr/cvae257
Vancouver
Mroueh A, Algara-Suarez P, Fakih W, Gong DS, Matsushita K, Park SH, et al. SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance. Cardiovascular Research. 2025;121(4):643-657. doi:10.1093/cvr/cvae257
BibTeX
@article{Mroueh2025,
author = {Mroueh, Ali and Algara-Suarez, Paola and Fakih, Walaa and Gong, Dal-Seong and Matsushita, Kensuke and Park, Sin-Hee and Amissi, Said and Auger, Cyril and Kauffenstein, Gilles and Meyer, Nicolas and Ohlmann, Patrick and Jesel, Laurence and Pieper, Michael Paul and Marchandot, Benjamin and Morel, Olivier and Mazzucotelli, Jean-Philippe and Schini-Kerth, Valérie B},
title = {SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance},
journal = {Cardiovascular Research},
year = {2025},
volume = {121},
number = {4},
pages = {643--657},
doi = {10.1093/cvr/cvae257}
}
EUVIMED